TRIM33 and non-small cell lung carcinoma: Therefore, targeting EMT and signaling pathways promoting EMT could be a great strategy in NSCLC treatment such as TIF1γ, a TGFβ signaling regulator, that could act as a tumor metastasis suppressor in NSCLC by inhibiting EMT induced by TGFβ [24].